

# âš¡ ADAPTIVE TRIAL LOGIC IMPLEMENTATION COMPLETE
**Date:** January 26, 2026  
**Version:** v2.0-PHASE3 (Adaptive Trial Logic)  
**Status:** âœ… **COMPLETE AND OPERATIONAL**  
**Protocol Compliance:** 9-Phase Development Protocol

---

## ğŸ¯ OBJECTIVE ACHIEVED

**Implemented epoch-based adaptive trial logic with mid-trial dose adjustments and arm stopping.**

```
BEFORE (v2.0-PHASE2):
Fixed dose â†’ all patients â†’ fixed trial design

AFTER (v2.0-PHASE3):
Initial dose â†’ interim analysis â†’ dose adjustment/arm stop â†’ remaining patients
```

**Impact:** Trials now simulate modern adaptive designs used by leading CROs.

---

## ğŸ“‹ IMPLEMENTATION SUMMARY

### **Phase 3.1 - Adaptive Rules Schema** âœ…
**File:** `PX_Engine/operations/TrialEngine.py`  
**Status:** Production schema defined

#### **Schema:**
```python
"adaptive_rules": {
    "metric": "auc_mg_h_per_L",  # or "cmax_mg_per_L", "max_effect", etc.
    "lower_bound": 100.0,        # Optional: trigger INCREASE_DOSE if below
    "upper_bound": 300.0,        # Optional: trigger REDUCE_DOSE if above
    "action": "REDUCE_DOSE",     # or "INCREASE_DOSE", "STOP_ARM"
    "dose_adjustment_factor": 0.75,  # For dose reductions (default 0.75)
    "increase_factor": 1.33,     # For dose increases (default 1.33)
    "interim_after_n": 10,       # Evaluate after N patients per arm
}
```

**Supported Metrics:**
- **PK Metrics:** `auc_mg_h_per_L`, `cmax_mg_per_L`, `cmin_steady_state_mg_per_L`
- **PD Metrics:** `max_effect`, `auec_h`, `time_above_threshold_h`, `mean_effect`

**Supported Actions:**
- `REDUCE_DOSE` - Multiply current dose by `dose_adjustment_factor` (e.g., 0.75)
- `INCREASE_DOSE` - Multiply current dose by `increase_factor` (e.g., 1.33)
- `STOP_ARM` - Halt patient enrollment for this arm

---

### **Phase 3.2 - Rule Evaluation Logic** âœ…
**File:** `PX_Engine/operations/TrialEngine.py`  
**Method:** `_evaluate_adaptive_rule()`  
**Status:** Production-grade threshold evaluation

#### **Evaluation Logic:**

```python
def _evaluate_adaptive_rule(...) -> Dict[str, Any]:
    """
    Evaluate adaptive rule at interim analysis.
    
    Returns decision dict with:
    - triggered: bool
    - action: "REDUCE_DOSE" | "INCREASE_DOSE" | "STOP_ARM" | None
    - reason: str (human-readable)
    - new_dose_mg: float
    """
    # 1. Get metric values accumulated so far
    mean_value = statistics.fmean(metric_values)
    
    # 2. Check bounds
    if upper_bound and mean_value > upper_bound:
        triggered = True
        action = "REDUCE_DOSE" or "STOP_ARM"
        new_dose = current_dose * dose_adjustment_factor
    
    elif lower_bound and mean_value < lower_bound:
        triggered = True
        action = "INCREASE_DOSE"
        new_dose = current_dose * increase_factor
    
    else:
        triggered = False
        action = None
        new_dose = current_dose
    
    return decision
```

**Features:**
- Computes mean of accumulated metric values
- Evaluates upper and lower bounds
- Deterministic decision-making (no RNG)
- Comprehensive logging

---

### **Phase 3.3 - Adaptation Actions** âœ…
**File:** `PX_Engine/operations/TrialEngine.py`  
**Method:** `run_trial()` (enhanced with epoch logic)  
**Status:** Full action execution implemented

#### **Epoch-Based Adaptation:**

```python
for i, patient in enumerate(population):
    # Check if arm stopped
    if arm_stopped:
        continue  # Skip remaining patients
    
    # Interim analysis checkpoint
    if adaptive_rules and i > 0 and i % interim_after_n == 0:
        decision = self._evaluate_adaptive_rule(...)
        adaptation_log.append(decision)
        
        # Execute action
        if decision["triggered"]:
            if action == "STOP_ARM":
                arm_stopped = True
            elif action in ["REDUCE_DOSE", "INCREASE_DOSE"]:
                current_dose_mg = decision["new_dose_mg"]
    
    # Run PK with current dose
    pk = simulate_one_compartment(dose_mg=current_dose_mg, ...)
```

**Actions:**

**1. REDUCE_DOSE:**
```python
# Example: 200mg â†’ 150mg (200 * 0.75)
new_dose_mg = current_dose_mg * dose_adjustment_factor
```

**2. INCREASE_DOSE:**
```python
# Example: 100mg â†’ 133mg (100 * 1.33)
new_dose_mg = current_dose_mg * increase_factor
```

**3. STOP_ARM:**
```python
# Stop enrolling patients
arm_stopped = True
# Remaining patients skipped
```

---

### **Phase 3.4 - Adaptation Logging** âœ…
**File:** `PX_Engine/operations/TrialEngine.py`  
**Status:** Comprehensive logging integrated

#### **Trial Result Structure (Enhanced):**
```python
{
    "trial_id": "...",
    "arms": [
        {
            "arm_id": "A1",
            "initial_dose_mg": 200.0,        # NEW
            "final_dose_mg": 150.0,          # NEW
            "arm_stopped": False,            # NEW
            "patients_enrolled": 20,         # NEW (actual vs planned)
            "n_patients": 20,                # Planned
            
            "adaptation_log": [              # NEW
                {
                    "patient_count": 10,
                    "metric": "auc_mg_h_per_L",
                    "mean_value": 350.5,
                    "lower_bound": None,
                    "upper_bound": 300.0,
                    "triggered": True,
                    "reason": "auc_mg_h_per_L mean (350.50) > upper_bound (300.0)",
                    "action": "REDUCE_DOSE",
                    "current_dose_mg": 200.0,
                    "new_dose_mg": 150.0
                },
                {
                    "patient_count": 20,
                    "metric": "auc_mg_h_per_L",
                    "mean_value": 265.3,
                    "triggered": False,
                    "reason": "auc_mg_h_per_L mean (265.30) within bounds",
                    ...
                }
            ],
            "adaptations_triggered": 1,      # NEW
            
            "exposure_summary": { ... },
            "pd_summary": { ... }
        }
    ],
    "adaptive_rules": { ... },               # NEW - provenance
    "constitutional": {
        "engine": "TRIAL_ENGINE_V2.0-ADAPTIVE-PKPD",  # Updated
        ...
    }
}
```

**Logging Features:**
- Every interim analysis logged
- Decision rationale included
- Dose changes tracked
- Arm stopping recorded
- Full auditability

---

## ğŸ§ª TESTING RESULTS

### **Phase 2-3 - Unit Testing** âœ…
**File:** `PX_Validation/tests/test_adaptive.py`  
**Tests:** 7 comprehensive unit tests  
**Result:** **7/7 passing (100%)**

**Test Coverage:**
```
TestAdaptiveRuleEvaluation (7 tests):
âœ… test_upper_bound_triggers_reduce_dose
âœ… test_lower_bound_triggers_increase_dose
âœ… test_within_bounds_no_trigger
âœ… test_upper_bound_triggers_stop_arm
âœ… test_pd_metric_evaluation
âœ… test_unknown_metric_no_trigger
âœ… test_no_data_no_trigger
```

**Status:** âœ… **ALL UNIT TESTS PASSING**

---

### **Phase 5 - Integration Testing** âœ…
**File:** `PX_Validation/tests/test_adaptive_integration.py`  
**Tests:** 7 integration tests  
**Result:** **7/7 passing (100%)**

**Test Coverage:**
```
TestAdaptiveTrialIntegration (7 tests):
âœ… test_no_adaptive_rules_backward_compat
âœ… test_adaptive_reduce_dose_triggers
âœ… test_adaptive_within_bounds_no_trigger
âœ… test_adaptive_stop_arm
âœ… test_adaptive_with_iiv (Phase 2+3 integration)
âœ… test_adaptive_with_pkpd (Phase 1+3 integration)
âœ… test_adaptation_logging_complete
```

**Key Findings:**
- Backward compatible (no adaptive_rules = Phase 2 behavior)
- REDUCE_DOSE works correctly (200mg â†’ 150mg)
- STOP_ARM halts enrollment (30 planned â†’ 10 enrolled)
- Works seamlessly with IIV (Phase 2)
- Works seamlessly with PK/PD (Phase 1)
- Comprehensive logging verified

**Status:** âœ… **ALL INTEGRATION TESTS PASSING**

---

### **Phase 6 - System Testing** âœ…
**File:** `PX_Validation/tests/PX_System_Test.py`  
**Result:** **46/46 tests passing (100%)**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘              SYSTEM TEST RESULTS                          â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ âœ… Tests Passing:              46/46 (100%)              â•‘
â•‘ âŒ Failures:                   0                         â•‘
â•‘ âš ï¸  Warnings:                   0                         â•‘
â•‘ ğŸ”´ Import Errors:              0                         â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

**Status:** âœ… **ZERO REGRESSIONS - SYSTEM INTEGRITY MAINTAINED**

---

### **Phase 7 - Regression Resolution** âœ…
**Status:** **NOT REQUIRED**  
**Reason:** Zero test failures, zero warnings, zero regressions  
**Verification:** All existing functionality maintained, backward compatible

---

## ğŸ“Š TOTAL TEST COVERAGE

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘        PHASE 3 (ADAPTIVE) TEST SUMMARY                    â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Unit Tests:                7/7 âœ… (100%)                 â•‘
â•‘ Integration Tests:         7/7 âœ… (100%)                 â•‘
â•‘ System Tests:              46/46 âœ… (100%)               â•‘
â•‘                                                           â•‘
â•‘ TOTAL TESTS:               60/60 âœ… (100%)               â•‘
â•‘ REGRESSION COUNT:          0                             â•‘
â•‘ WARNING COUNT:             0                             â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

**Cumulative v2.0 Tests:**
- Phase 1 (PK/PD): 20 tests
- Phase 2 (IIV): 17 tests
- Phase 3 (Adaptive): 14 tests
- System Tests: 46 tests
- **Total: 97 tests passing**

---

## ğŸ”’ CONSTITUTIONAL COMPLIANCE

### **L51: Zero Placeholders** âœ…
- Adaptation decisions based on actual accumulated data
- No fabricated triggers or synthetic decisions
- All thresholds explicitly defined in protocol
- Dose adjustments deterministic (factor-based)

### **L34: No Fabrication** âœ…
- Adaptive status explicit in trial results
- Adaptation log complete and traceable
- Decision rationale recorded for every interim
- Constitutional metadata updated for adaptive trials

### **ALCOA+ (Evidence Packages)** âœ…
- Adaptive rules stored for provenance
- Adaptation log immutable (append-only)
- Dose changes auditable
- Patient enrollment tracking accurate

---

## ğŸ“ˆ REAL-WORLD USAGE EXAMPLES

### **Example 1: Dose Reduction for High Exposure**
```python
protocol = {
    "trial_id": "TRIAL-REDUCE-001",
    "duration_days": 28.0,
    "arms": [{
        "arm_id": "A1",
        "label": "200mg QD",
        "dose_mg": 200.0,
        "dosing_interval_h": 24.0,
        "n_patients": 30,
    }],
    "adaptive_rules": {
        "metric": "auc_mg_h_per_L",
        "upper_bound": 300.0,  # Safety threshold
        "action": "REDUCE_DOSE",
        "dose_adjustment_factor": 0.75,
        "interim_after_n": 10,  # Check every 10 patients
    }
}

result = trial_engine.run_trial(protocol, admet)

# Result:
# - Patients 1-10: 200mg â†’ AUC mean = 350 mgÂ·h/L
# - Interim 1: REDUCE_DOSE triggered (350 > 300)
# - Patients 11-20: 150mg â†’ AUC mean = 265 mgÂ·h/L
# - Interim 2: No trigger (265 < 300)
# - Patients 21-30: 150mg â†’ Final dose = 150mg
```

---

### **Example 2: Arm Stopping for Safety**
```python
protocol = {
    "trial_id": "TRIAL-STOP-001",
    "duration_days": 14.0,
    "arms": [{
        "arm_id": "A1",
        "label": "400mg QD (high)",
        "dose_mg": 400.0,
        "dosing_interval_h": 24.0,
        "n_patients": 40,
    }],
    "adaptive_rules": {
        "metric": "cmax_mg_per_L",
        "upper_bound": 10.0,  # Safety limit
        "action": "STOP_ARM",
        "interim_after_n": 15,
    }
}

result = trial_engine.run_trial(protocol, admet, variability=...)

# Result:
# - Patients 1-15: Cmax mean = 12.5 mg/L
# - Interim 1: STOP_ARM triggered (12.5 > 10.0)
# - Arm stopped: 15 patients enrolled (40 planned)
# - arm["arm_stopped"] = True
# - arm["patients_enrolled"] = 15
```

---

### **Example 3: Adaptive with PK/PD (Phase 1+3)**
```python
protocol = {
    "trial_id": "TRIAL-PD-ADAPT-001",
    "duration_days": 21.0,
    "arms": [{
        "arm_id": "A1",
        "label": "150mg QD",
        "dose_mg": 150.0,
        "dosing_interval_h": 24.0,
        "n_patients": 24,
    }],
    "adaptive_rules": {
        "metric": "max_effect",  # PD metric
        "upper_bound": 0.8,      # Efficacy ceiling
        "action": "REDUCE_DOSE",
        "dose_adjustment_factor": 0.85,
        "interim_after_n": 12,
    }
}

pd_params = {
    "emax": 0.95,
    "ec50": 5.0,
    "hill": 2.0,
}

result = trial_engine.run_trial(protocol, admet, pd_params=pd_params)

# Result:
# - Patients 1-12: Max Effect mean = 0.84
# - Interim 1: REDUCE_DOSE triggered (0.84 > 0.8)
# - Patients 13-24: Dose reduced to 127.5mg
# - Final: Max Effect = 0.75 (within target)
```

---

### **Example 4: Adaptive with IIV (Phase 2+3)**
```python
result = trial_engine.run_trial(
    protocol={
        "trial_id": "TRIAL-IIV-ADAPT-001",
        "arms": [{"dose_mg": 180.0, "n_patients": 21, ...}],
        "adaptive_rules": {
            "metric": "auc_mg_h_per_L",
            "upper_bound": 320.0,
            "action": "REDUCE_DOSE",
            "interim_after_n": 14,
        }
    },
    admet=admet,
    variability={
        "clearance_variation": 0.3,
        "vd_variation": 0.25,
        "n_tiers": 7
    }
)

# Result:
# - Patients 1-14: AUC mean = 285 Â± 68 mgÂ·h/L (realistic variability)
# - Interim 1: No trigger (285 < 320)
# - Patients 15-21: Same dose
# - Population distribution preserved with adaptive logic
```

---

## ğŸ’¡ BENEFITS DELIVERED

### **For Partners:**
1. **Modern Trial Designs**
   - Before: Fixed dose throughout trial
   - After: Adaptive dose adjustments mid-trial (like real protocols)

2. **Safety Monitoring**
   - Interim analyses detect high exposure early
   - Automatic dose reduction or arm stopping
   - Risk mitigation built into simulation

3. **Dose Optimization**
   - Adaptively find optimal dose during trial
   - Reduce overexposure without stopping trial
   - Increase underperforming doses

4. **Regulatory Compliance**
   - Comprehensive adaptation logs
   - Decision rationale documented
   - Auditability for FDA submissions

### **For System:**
1. **v2.0 Roadmap Progress**
   - Phase 1 (PK/PD): âœ… Complete
   - Phase 2 (IIV): âœ… Complete
   - Phase 3 (Adaptive): âœ… Complete
   - Phase 4 (Dose Opt): ğŸ”´ Ready to begin

2. **Technical Foundation**
   - Epoch-based adaptation scalable
   - Backward compatible (adaptive_rules optional)
   - Integrates with PK/PD (Phase 1)
   - Integrates with IIV (Phase 2)

3. **Competitive Advantage**
   - Adaptive trials = modern CRO capability
   - Partners can simulate adaptive protocols
   - FDA-grade logging and documentation

---

## ğŸš€ FUTURE ENHANCEMENTS

### **Phase 4+ Opportunities:**
1. **Multi-Metric Rules**
   - Combine PK and PD metrics
   - Example: "If AUC > 300 OR max_effect > 0.9 â†’ REDUCE_DOSE"

2. **Response-Adaptive Randomization**
   - Adjust arm allocation based on interim results
   - Bayesian adaptive designs

3. **Dose Titration Protocols**
   - Intra-patient dose adjustments
   - Escalation/de-escalation schemes

4. **Futility Analysis**
   - Stop arms with low probability of success
   - Bayesian predictive probability

5. **Sample Size Re-estimation**
   - Adjust n_patients based on observed variability
   - Maintain power with smaller samples

---

## ğŸ“ FILES MODIFIED/CREATED

### **Implementation Files:**
```
PX_Engine/operations/
â””â”€â”€ TrialEngine.py                       (ENHANCED - adaptive logic)
    â”œâ”€â”€ adaptive_rules schema            (NEW docstring)
    â”œâ”€â”€ _evaluate_adaptive_rule()        (NEW method)
    â”œâ”€â”€ epoch-based adaptation           (NEW loop logic)
    â”œâ”€â”€ adaptation logging               (NEW result fields)
    â””â”€â”€ constitutional notes             (UPDATED)
```

### **Test Files:**
```
PX_Validation/tests/
â”œâ”€â”€ test_adaptive.py                     (NEW - 7 unit tests)
â””â”€â”€ test_adaptive_integration.py         (NEW - 7 integration tests)
```

### **Documentation Files:**
```
PX_Audit/reports/
â””â”€â”€ ADAPTIVE_IMPLEMENTATION_COMPLETE.md  (NEW - this document)
```

---

## âœ… ADVANCEMENT CHECKLIST

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘            PHASE 3 ADVANCEMENT CHECKLIST                     â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ âœ… Adaptive rules schema defined                            â•‘
â•‘ âœ… Rule evaluation logic implemented                        â•‘
â•‘ âœ… REDUCE_DOSE action implemented                           â•‘
â•‘ âœ… INCREASE_DOSE action implemented                         â•‘
â•‘ âœ… STOP_ARM action implemented                              â•‘
â•‘ âœ… Epoch-based adaptation implemented                       â•‘
â•‘ âœ… Adaptation logging comprehensive                         â•‘
â•‘                                                              â•‘
â•‘ âœ… Unit tests: 7/7 passing (100%)                           â•‘
â•‘ âœ… Integration tests: 7/7 passing (100%)                    â•‘
â•‘ âœ… System tests: 46/46 passing (100%)                       â•‘
â•‘ âœ… No regressions                                          â•‘
â•‘ âœ… Zero warnings                                           â•‘
â•‘                                                              â•‘
â•‘ âœ… Backward compatible (adaptive_rules optional)            â•‘
â•‘ âœ… Integrates with IIV (Phase 2)                           â•‘
â•‘ âœ… Integrates with PK/PD (Phase 1)                         â•‘
â•‘ âœ… Constitutional compliance (L51/L34/ALCOA+)              â•‘
â•‘                                                              â•‘
â•‘ âœ… ADAPTIVE_IMPLEMENTATION_COMPLETE.md created              â•‘
â•‘ âœ… Documentation complete                                   â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

**ALL CRITERIA MET âœ…**

---

## ğŸ“ PROTOCOL COMPLIANCE SUMMARY

**9-Phase Development Protocol Compliance:**

```
Phase 1 (Implementation):      âœ… COMPLETE
Phase 2 (Unit Testing):        âœ… COMPLETE (7 tests)
Phase 3 (Isolated Test):       âœ… COMPLETE (100% pass)
Phase 4 (Integration):         âœ… COMPLETE
Phase 5 (Integration Test):    âœ… COMPLETE (7 tests)
Phase 6 (System Test):         âœ… COMPLETE (46/46 pass)
Phase 7 (Regression Fix):      âœ… COMPLETE (0 regressions)
Phase 8 (Documentation):       âœ… COMPLETE (this doc)
Phase 9 (Advancement):         âœ… READY TO ADVANCE
```

**Protocol Status:** âœ… **FULLY COMPLIANT (3rd time!)**

---

## ğŸ¯ PHASE 3 STATUS

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                                                              â•‘
â•‘     ğŸ‰ PHASE 3 (ADAPTIVE TRIAL LOGIC) COMPLETE ğŸ‰           â•‘
â•‘                                                              â•‘
â•‘  PREDATOR X now simulates modern adaptive trials like       â•‘
â•‘  leading CROs with mid-trial dose adjustments and           â•‘
â•‘  comprehensive decision logging.                            â•‘
â•‘                                                              â•‘
â•‘  âœ… Epoch-based adaptation (interim analyses)               â•‘
â•‘  âœ… Three actions (REDUCE_DOSE, INCREASE_DOSE, STOP_ARM)    â•‘
â•‘  âœ… PK and PD metric support                                â•‘
â•‘  âœ… Comprehensive adaptation logging                        â•‘
â•‘  âœ… 60 tests passing (100% Phase 1+2+3)                     â•‘
â•‘  âœ… Zero regressions                                        â•‘
â•‘  âœ… Backward compatible                                     â•‘
â•‘  âœ… Constitutional compliance maintained                    â•‘
â•‘                                                              â•‘
â•‘  Ready to advance to Phase 4 (Dose Optimization v2)         â•‘
â•‘                                                              â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

**Implementation Completed:** January 26, 2026  
**Status:** âœ… **OPERATIONAL AND READY FOR PRODUCTION**  
**Next Phase:** Phase 4 - Dose Optimization v2  

---

**âš¡ ADAPTIVE TRIALS: FROM FIXED TO FLEXIBLE - COMPLETE âš¡**
